1Semana
Some good news: $MMED spin-off, FDA approval for the Hugo system, but the stock price is back where it was 8 months ago.
The market does not (yet) seem to be responding to the strategic realignment with a revaluation.
The market does not (yet) seem to be responding to the strategic realignment with a revaluation.
•
11
•
1Semana
@CaYaRo But at least it's heading in the right direction.
It's just a bit of a slow-moving track that takes its time 😅
It's just a bit of a slow-moving track that takes its time 😅
•
11
•